title: In Vitro and In Vivo Assessment of Angiotensin-Converting Enzyme (ACE) Inhibitory Activity of Fermented Soybean Milk by Lactobacillus casei Strains.
abstract: Angiotensin-converting enzyme (ACE) inhibitory activity of fermented soybean milk (FSM) by Lactobacillus casei strains in vitro was investigated in this study. Effects of fermented soybean milk administration by gavage on systolic blood pressure and diastolic blood pressure was also evaluated in spontaneously hypertensive rats (SHR) rats and Wistar-Kyoto (WKY) rats. Results showed that, CICC 20280 and CICC 23184 FSM showed high ACE inhibitory activity in vitro test and ACE inhibitory activity of CICC 23184 FSM was higher than CICC 20280 FSM. The bioactive substances of FSM were peptide and γ-aminobutyric acid (GABA). Their contents in CICC 20280 FSM and CICC 23184 FSM were 3.97 ± 0.67 mg/ml (peptide), 1.71 ± 0.36 mg/ml (GABA) and 5.17 ± 0.22 mg/ml (peptide), 1.57 ± 0.21 mg/ml (GABA), respectively. Moreover, CICC 20280 and CICC 23184 FSM administration by gavage could effectively lower the blood pressure of SHR to a normal level, while there was no effect on blood pressure of WKY rats. This result indicated that the bioactive substances could play an antihypertensive role when the blood pressure was not within the normal levels (high levels).
authors.affiliation: Northeast Agricultural University, Harbin, 150030, Heilongjiang, China.
authors.forename: Zhijie
authors.initials: Z
authors.lastname: Bao
authors.affiliation: Northeast Agricultural University, Harbin, 150030, Heilongjiang, China. yjchi323@126.com.
authors.forename: Yujie
authors.initials: Y
authors.lastname: Chi
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage* / Q000378:metabolism*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D005260:Female; D005285:Fermentation; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D007780:Lacticaseibacillus casei / Q000378:metabolism*; D008297:Male; D007703:Peptidyl-Dipeptidase A / Q000378:metabolism; D010936:Plant Extracts / Q000008:administration & dosage* / Q000378:metabolism*; D051381:Rats; D011918:Rats, Inbred SHR; D011921:Rats, Inbred WKY; D041942:Soy Milk / Q000737:chemistry*; D013025:Glycine max / Q000378:metabolism / Q000382:microbiology*
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D010936:Plant Extracts; D007703:Peptidyl-Dipeptidase A